Product Theater: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis

Topics: Dupixent (dupilumab) Injection – The First Biologic for Adults with Controlled Moderate-to-Severe Atopic Dermatitis Faculty: Andrew Blauvelt, MD, MBA This Product Theater, sponsored by Regeneron Pharmaceuticals / Sonofi Genzyme, is from the SDPA Annual Summer Dermatology Conference 2017.

Om Podcasten

The SDPAs online media resource center for both clinical and professional topics. Interviews with dermatology PAs, doctors, and industry leaders as well as procedures, podcasts, sessions, panels and much more!! The one-stop-shop for everything related to the SDPA and dermatology. For more information, visit dermPA.org and Dermcast.tv.